Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Medical Devices

India renal denervation catheter market to grow at 11% CAGR through 2033, forecasts GlobalData

The rising prevalence of hypertension in India has become a significant health concern, leading to serious health issues and increased mortality rates. Renal denervation has been emerging as one of the potential solutions to address these challenges, particularly for resistant hypertension. Against this background, the renal denervation catheters market in India is expected to grow […]
Read more

GlobalData highlights shift in neuromodulation devices landscape as Neuralace Medical’s Axon Therapy receives US FDA clearance

Neuralace Medical, a California-based innovator in pain management technology, has recently received the FDA clearance for its Axon Therapy, a non-invasive, magnetic peripheral nerve stimulation (mPNS) treatment for chronic painful diabetic neuropathy (PDN). The approval marks a significant turning point in the neuromodulation field. It reflects the industry’s commitment to developing innovative, patient-centric solutions that […]
Read more

FDA approval of Darmiyan BrainSee major step forward in Alzheimer’s diagnosis during awareness month, says GlobalData

January marks the start of Alzheimer’s Awareness Month, as set by the Alzheimer Society of Canada. California-based brain technology (deep-tech) company Darmiyan’s clinical brain test “BrainSee” has recently secured FDA approval. The diagnosis rates for Alzheimer’s and dementia are currently quite low, so frequent and improved diagnostic methods such as these are needed to treat […]
Read more

National Birth Defects Awareness Month highlights need for increased congenital syphilis testing in US, says GlobalData

January is observed as National Birth Defects Awareness and Prevention Month annually to raise awareness about birth defects in the US. In November 2023, the Centers for Disease Control and Prevention (CDC) issued a statement drawing attention to the steeply escalating incidence of syphilis cases in newborns in the US, indicating a 10-fold increase in […]
Read more

China reproductive health devices market to reach $450 million in 2030, forecasts GlobalData

China has been witnessing an increasing demand for various reproductive health tests and devices due to several factors such as a growing population, rising awareness about reproductive health, improving healthcare infrastructure, and changing lifestyles. Against this backdrop, China’s reproductive health devices market is expected to reach $450 million in 2030, forecasts GlobalData, a leading data […]
Read more

Bitcoin ETF approval underscores maturation of cryptocurrency space, says GlobalData

In a groundbreaking move equipped to reshape the financial industry, the Securities and Exchange Commission (SEC) has officially approved the eagerly awaited Bitcoin Exchange-Traded Fund (ETF). This historic approval underscores the maturation of the cryptocurrency space and the increasing acknowledgment of its potential as a legitimate and viable asset class, says GlobalData, a leading data […]
Read more

Integration of Abbott and Tandem devices provide new option for diabetic patients, says GlobalData

Abbott and Tandem Diabetes Care recently announced the wireless integration of Abbott’s FreeStyle Libre 2 Plus continuous glucose monitor with the Tandem t:slim X2 insulin pump in the US. This announcement provides another useful treatment option for diabetic patients requiring insulin therapy and who wish to utilize continuous glucose monitoring, says GlobalData, a leading data […]
Read more

AI and strategic partnerships to help Singapore accelerate transformation of kidney disease management, says GlobalData

Kidney failure poses a major health challenge in the Asia Pacific (APAC) region, with Singapore standing out as one of the APAC countries with a high incidence of end-stage renal disease. To address this issue, Singapore is actively working with national and international organizations to develop and implement new artificial intelligence (AI)-based models. This is […]
Read more

GlobalData foresees paradigm shift in neurostimulation as Medtronic’s Percept DBS system attains CE Mark

The recent attainment of the CE mark for Medtronic‘s Percept deep brain stimulation (DBS)  system marks a significant milestone in the field of neurostimulation, driving advancements in tailored therapies. The system’s personalized approach mirrors a broader industry shift, shaping neurostimulation technologies. With a focus beyond traditional neurological disorders, the CE mark propels the market towards […]
Read more

Global partnership deals to foster Singapore AimSG pilot project advancement, says GlobalData

Singapore’s healthcare sector is advancing significantly by incorporating artificial intelligence (AI) into medical practices, marking a notable leap forward. The Advanced and Integrated Manufacturing for Sustainable Growth (AimSG) platform has been instrumental in this expansion, focusing on expediting the validation and deployment of trustworthy AI imaging models within Singapore’s public healthcare institutions. This initiative has […]
Read more

GlobalData predicts $1.1 billion growth in medical device cybersecurity market amid rising threats

The rapid integration of new technology and digital health devices into healthcare systems has revolutionized patient care and diagnostic processes. However, the increased reliance on these devices has also exposed the healthcare industry to cybersecurity threats. According to the recent report, Cybersecurity in Medical Devices, the market for cybersecurity in medical devices is expected to […]
Read more

Microbubbles are revolutionizing ultrasound imaging and personalized medicine, says GlobalData

The ultrasound contrast agents (microbubbles) market is driven by their role in enhancing diagnostic capabilities and revolutionizing treatment methods. The demand for microbubbles will stem from the growing preference for non-invasive procedures, personalized medicine, and innovations in imaging technology – especially in cardiology, oncology, and neurology, where precise imaging is critical for accurate diagnosis and […]
Read more

FDA’s LDT regulation proposal needs to strike balance between safety and innovation, says GlobalData

The US Food and Drug Administration (FDA) has proposed a significant regulatory change, seeking to classify laboratory-developed tests (LDTs) as medical devices. Unveiled in October 2023, the proposal aims to bolster the safety and effectiveness of these tests to safeguard patients. However, opposition from groups like ARUP Laboratories, under the leadership of CEO Andy Theurer, […]
Read more
1 … 16 17 18 19 20 … 51